Surrozen, Inc.
SRZNNasdaqCIK 1824893HealthcareFiscal year ends Dec 31
Reports and events: 114 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2220:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-429027 |
| 2026-10-2021:04 ET | 8-K | 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-426828 |
| 2026-10-0212:05 ET | 8-K | 8.01 Other events | 0001193125-26-411298 |
| 2026-08-0620:23 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338120 |
| 2026-08-0620:15 ET | 8-K | 2.02 Results of operations | 0001193125-26-338068 |
| 2026-05-1810:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-227857 |
| 2026-05-1420:13 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-224037 |
| 2026-05-0620:38 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-209179 |
| 2026-05-0620:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208999 |
| 2026-04-0120:23 ET | DEF 14A | Proxy statementPeriod 2026-04-01 | 0001193125-26-137976 |
| 2026-03-2320:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-119818 |
| 2026-03-2320:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-119757 |
| 2026-01-3021:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-031798 |
| 2026-01-2223:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-019817 |
| 2025-11-0721:24 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272422 |
| 2025-11-0721:11 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001193125-25-272363 |
| 2025-10-1720:14 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-25-242518 |
| 2025-08-2920:58 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-112253 |
| 2025-08-0820:14 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105847 |
| 2025-08-0820:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105839 |
| 2025-05-1520:22 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-072696 |
| 2025-05-0920:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-068046 |
| 2025-05-0920:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-068011 |
| 2025-04-0220:17 ET | DEF 14A | Proxy statementPeriod 2025-05-14 | 0000950170-25-049352 |
| 2025-03-3120:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-047712 |
| 2025-03-3120:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047702 |
| 2025-03-2801:19 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-047114 |
| 2025-03-2820:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-046769 |
| 2025-03-2420:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-061361 |
| 2024-11-0621:13 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122318 |
| 2024-11-0614:07 ET | 8-K | 2.02 Results of operations | 0000950170-24-121856 |
| 2024-10-0220:28 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-111493 |
| 2024-08-1220:14 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095443 |
| 2024-08-1220:08 ET | 8-K | 2.02 Results of operations | 0000950170-24-095414 |
| 2024-07-0120:41 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-079690 |
| 2024-06-0720:35 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-070741 |
| 2024-05-0820:18 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055706 |
| 2024-05-0820:12 ET | 8-K | 2.02 Results of operations | 0000950170-24-055667 |
| 2024-04-2320:25 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0000950170-24-046931 |
| 2024-04-1720:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-099085 |
| 2024-04-1020:38 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-043399 |
| 2024-04-0822:19 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-089766 |
| 2024-04-0221:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-24-040337 |
| 2024-04-0112:52 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-038902 |
| 2024-02-0711:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-011936 |
| 2024-01-1813:41 ET | 8-K | 8.01 Other events | 0000950170-24-005198 |
| 2023-12-1322:14 ET | 8-K | 5.03 Amendment to articles or bylaws | 0000950170-23-070103 |
| 2023-12-1121:08 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0000950170-23-069405 |
| 2023-11-0821:17 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061150 |
| 2023-11-0821:09 ET | 8-K | 2.02 Results of operations | 0000950170-23-061101 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.